Manager
ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U.
See the CNMV manager universe →
Fund page
GESTION BOUTIQUE VII, FI
Category
—
Latest period
H2 2025
Positions
36
Portfolio as of 2025-12-31. Source: periodic filing with the CNMV. View original filing (PDF)
Full portfolio
Every position in the latest periodic filing, largest weight first. Aggregates ("other equities...") are baskets of small positions the filing itself does not break out line by line.
36
Company
Type
Country
Weight
Price
This period's moves
H2 2025 vs H1 2025 (estimated)
New: 29
Exits: 33
Increases: 4
Cuts: 2
+ ACCIONES|BAYER
Enters the portfolio at 3.00% weight.
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a strategic alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft has a strategic alliance Henry Ford Health. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
View company page →− ACCIONES|Centrus Energy Corp
Leaves the portfolio; it was 4.31% of weight.
− ACCIONES|Rheinmetall Ag
Leaves the portfolio; it was 3.93% of weight.
− ACCIONES|Spotify Technology
Leaves the portfolio; it was 3.83% of weight.
− ACCIONES|Gaztransport et Tech
Leaves the portfolio; it was 3.68% of weight.
− ACCIONES|Byrna Technologies I
Leaves the portfolio; it was 3.30% of weight.
− ACCIONES|Netflix, Inc.
Leaves the portfolio; it was 2.87% of weight.
− ACCIONES|DEUTSCHE TEL.
Leaves the portfolio; it was 2.59% of weight.
− ACCIONES|Sterling Infrastruct
Leaves the portfolio; it was 2.47% of weight.
− ACCIONES|Technip Energies NV
Leaves the portfolio; it was 2.40% of weight.
− ACCIONES|kkr&Co Inc-A
Leaves the portfolio; it was 2.37% of weight.
− ACCIONES|Rolls-Royce Group pl
Leaves the portfolio; it was 2.37% of weight.
Rolls-Royce Holdings plc designs and manages mission-critical power systems in the United Kingdom and internationally. The company operates through three segments: Civil Aerospace, Defence, and Power Systems. The Civil Aerospace segment develops, manufactures, markets, and sells aero engines for large commercial aircraft, regional jet, and business aviation markets, as well as provides aftermarket services. The Defence segment is involved in the development, manufacture, marketing, and sale of military aero engines, naval engines, and submarine nuclear power plants, as well as offers aftermarket services. The Power Systems segment engages in the development, manufacture, marketing, and sale of integrated solutions for onsite power and propulsion under the mtu brand name. Rolls-Royce Holdings plc was founded in 1884 and is headquartered in London, the United Kingdom.
View company page →− ACCIONES|Kongsberg Gruppen AS
Leaves the portfolio; it was 2.28% of weight.
− ACCIONES|Corcept Therapeutics
Leaves the portfolio; it was 2.28% of weight.
− ACCIONES|E.on AG (Xetra)
Leaves the portfolio; it was 2.23% of weight.
− ACCIONES|Amphenol Corporation
Leaves the portfolio; it was 1.90% of weight.
− ACCIONES|3I GROUP ORD
Leaves the portfolio; it was 1.90% of weight.
− ACCIONES|Allianz AG
Leaves the portfolio; it was 1.88% of weight.
− ACCIONES|Verona Pharma PLC
Leaves the portfolio; it was 1.82% of weight.
− ACCIONES|SAP - AG
Leaves the portfolio; it was 1.80% of weight.
− ACCIONES|SECTRA AB
Leaves the portfolio; it was 1.80% of weight.
− ACCIONES|Carpenter Technology
Leaves the portfolio; it was 1.77% of weight.
− ACCIONES|K92 Mining Inc
Leaves the portfolio; it was 1.77% of weight.
− ACCIONES|Cotsco Wholesale
Leaves the portfolio; it was 1.77% of weight.
− ACCIONES|TALEN ENERGY CORP
Leaves the portfolio; it was 1.76% of weight.
− ACCIONES|Dundee Precious Meta
Leaves the portfolio; it was 1.72% of weight.
− ACCIONES|IonQ Inc
Leaves the portfolio; it was 1.66% of weight.
− ACCIONES|Palantir Technologie
Leaves the portfolio; it was 1.65% of weight.
− ACCIONES|Casella Waste System
Leaves the portfolio; it was 1.65% of weight.
− ACCIONES|Accs. Boston Scienti
Leaves the portfolio; it was 1.61% of weight.
− ACCIONES|Maire Tecnimont SpA
Leaves the portfolio; it was 1.60% of weight.
− ACCIONES|Caretrust Reit Inc
Leaves the portfolio; it was 1.53% of weight.
− ACCIONES|Stride Inc
Leaves the portfolio; it was 1.35% of weight.
Fixed income
Declared FI exposure
78,300 €
% of portfolio
3.2%
Positions
1
Issuers
0
Sovereign: 0 €
Corporate: 0 €
Repos / treasury management: 78,300 €
Maturity ladder
Observed contractual maturity of each position, repos excluded. Matured/≤3 months includes bonds maturing in the first days after the period close.
Maturity
Positions
Exposure
%
Matured or ≤3 months
0
0 €
0.0%
3-6 months
0
0 €
0.0%
6-12 months
0
0 €
0.0%
1-2 years
0
0 €
0.0%
2-5 years
0
0 €
0.0%
5-10 years
0
0 €
0.0%
> 10 years
0
0 €
0.0%
Unknown
0
0 €
0.0%
Disclaimer
This is not financial advice. The portfolio comes from the periodic report the fund files with the CNMV and lags the real close of the period: it is a snapshot of the end of each half-year, not a real-time portfolio.